Be part of the knowledge.™

Geriatrics

1511

LikeLikedUnlike

Addressing Shingles Risk in Adults Ages 50 to 55
VacciNation
Addressing Shingles Risk in Adults Ages 50 to 55
- Alexandria May, PharmD, BCPS
  Peer
- William Schaffner, MD
  Peer
Gaps in Shingles Vaccination: What Clinicians Need to Know
VacciNation
Gaps in Shingles Vaccination: What Clinicians Need to Know
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
Advances in Women's Health
Menopause Reimagined: The Role of Hormonal IUDs in Perimenopausal Care
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Mary Jane Minkin, MD
  Peer
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
NeuroFrontiers
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Michael Salvatore, PhD
  Peer
- Vicki Nejtek-Salvatore, PhD
  Peer
Managing Bleeding Risk in Fracture Patients on Anticoagulation
Clinician's Roundtable
Managing Bleeding Risk in Fracture Patients on Anticoagulation
- Alexandria May, PharmD, BCPS
  Peer
- Clay Spitler, MD
  Peer
Exploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
AudioAbstracts
Exploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
- Hallie Blevins, PhD
  Peer
advertisement

Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages
CME/CE
Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages
- Anton P. Porsteinsson, MD
  Peer
- Vijay K. Ramanan, MD, PhD
  Peer
1.00 credits
advertisement

Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Medical Industry Feature
Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
- Marwan Sabbagh, MD, FAAN, CCR
  Peer
- Cara Leahy, DO
  Peer
- David Weisman, MD
  Peer
Insights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
Medical Industry Feature
Insights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
- Jennifer Caudle, DO, FACOFP
  Peer
- Felicia Cosman, MD
  Peer
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Medical Industry Feature
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- George Grossberg, MD
  Peer
- Angela Sanford, MD, CMD
  Peer
Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Medical Industry Feature
Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
- Yuval Zabar, MD
  Peer
- Michelle Mielke, PhD
  Peer
- Henrik Zetterberg, MD, PhD
  Peer
Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
Medical Industry Feature
Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression
- Holly M. Brothers, PhD
  Peer
- Niklas Mattsson-Carlgren, MD, PhD
  Peer
Managing Bleeding Risk in Fracture Patients on Anticoagulation
Clinician's Roundtable
Managing Bleeding Risk in Fracture Patients on Anticoagulation
- Alexandria May, PharmD, BCPS
  Peer
- Clay Spitler, MD
  Peer

Medical News
Aging Reshapes the Human Breast at Cellular and Structural Levels, Offering New…
04/01/2026
Medical News
Evoke and Evoke+: Oral Semaglutide in Early Alzheimer's Disease
03/24/2026
Medical News
No Increase in Neovascular AMD Risk After Cataract Surgery
03/18/2026
Medical News
Chlorpyrifos Exposure Linked with Higher Parkinson’s risk: UCLA Health Report
03/18/2026
Medical News
Racial and Biological Diversity in Early Alzheimer Brain Markers
03/16/2026
Medical News
NOA Longitudinal Validation On Home OCT for AMD
03/16/2026

Program Chapters

Segment Chapters

Playlist:

Recommended